- Home
- HNVR vs BHST Comparison
HNVR vs BHST Comparison
Compare HNVR & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNVR
- BHST
- Stock Information
- Founded
- HNVR 2008
- BHST 2007
- Country
- HNVR United States
- BHST Canada
- Employees
- HNVR N/A
- BHST N/A
- Industry
- HNVR Commercial Banks
- BHST
- Sector
- HNVR Finance
- BHST
- Exchange
- HNVR Nasdaq
- BHST Nasdaq
- Market Cap
- HNVR 167.7M
- BHST 166.4M
- IPO Year
- HNVR 2022
- BHST N/A
- Fundamental
- Price
- HNVR $22.20
- BHST $12.65
- Analyst Decision
- HNVR Buy
- BHST Strong Buy
- Analyst Count
- HNVR 2
- BHST 2
- Target Price
- HNVR $23.75
- BHST $13.00
- AVG Volume (30 Days)
- HNVR 12.8K
- BHST 108.2K
- Earning Date
- HNVR 10-23-2025
- BHST 11-24-2025
- Dividend Yield
- HNVR 1.78%
- BHST N/A
- EPS Growth
- HNVR N/A
- BHST N/A
- EPS
- HNVR 1.53
- BHST N/A
- Revenue
- HNVR $68,211,000.00
- BHST $30,192,000.00
- Revenue This Year
- HNVR N/A
- BHST $116.40
- Revenue Next Year
- HNVR $17.15
- BHST $55.91
- P/E Ratio
- HNVR $14.73
- BHST N/A
- Revenue Growth
- HNVR 14.14
- BHST 57.83
- 52 Week Low
- HNVR $17.86
- BHST $4.66
- 52 Week High
- HNVR $27.14
- BHST $12.80
- Technical
- Relative Strength Index (RSI)
- HNVR N/A
- BHST 62.85
- Support Level
- HNVR N/A
- BHST $7.82
- Resistance Level
- HNVR N/A
- BHST $12.80
- Average True Range (ATR)
- HNVR 0.00
- BHST 1.17
- MACD
- HNVR 0.00
- BHST 0.07
- Stochastic Oscillator
- HNVR 0.00
- BHST 68.88
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.